PTC Therapeutics, Inc. is a pioneering biopharmaceutical firm based in South Plainfield, New Jersey, dedicated to creating innovative therapies for rare genetic disorders. Leveraging its expertise in RNA modulation and small molecule therapeutics, PTC has developed a robust pipeline of advanced product candidates aimed at addressing significant unmet medical needs. The company's strategic focus on transformative treatments positions it as a key player in the rare disease space, driving advancements that significantly improve patient outcomes for those suffering from serious and underserved conditions.